Drug Device Combination 2014-2025 Market Research Report, by Key Vendors; Abbott Laboratories, Stryker, Medtronic, Teleflex Incorporated, and Allergan, Inc.

According to the latest study published by AnalystView Market Insights, by the end of 2025, the global drug device combination market is anticipated to reach USD 165.4 billion with growth rate of 9.8%.
Drug device combination products are defined as the combination of diagnostics and therapeutic agents to provide safe and effective treatment options to patients. In terms of different products, drug device combination market is categorized as Orthopedic products,Inhalers, Photodynamic therapy devices, Infusion pumps, Transdermal patches, Drug eluting stents, Antimicrobial catheters and Others. The purpose of most of these combinational devices is to either boost the efficiency of devices or to provide product safety through better drug delivery. Among these different devices, transdermal patches and inhaler segment accounted for USD 61.28 billion in 2016 and is expected to dominate the total market collectively. Infusion pumps segment is further divided into Volumetric, Disposable, Syringe, Ambulatory and others.

Get access to exclusive PDF brochure of this study @
www.analystviewmarketinsights.com/request_sample/av111/

Regionally, North America, and Europe dominated the global market. Rising research and development activities in this area stimulated the market growth in these regions. In 2016, North America recorded USD 38.23 billion and is expected to grow with 6.8% growth rate during the forecast period. Rising demand for drug combinational devices coupled with research and development initiatives will help the region to grow further at constant rate.
In Asia Pacific region, countries such as China and India shows their great potential to capture large share of the global market. TEH SENG Pharmaceutical Mfg. Co., Ltd., ProStrakan Group, Zhejiang Bangli Medical Products Co., Ltd., Zhejiang Yinda Biotechnology Co., Ltd., and Stemedica are some of the leading supplier and manufacturer of drug device combinations in China.

Key companies such as Abbott, Stryker, Medtronic, Teleflex Incorporated, and Allergan, Inc. are profiled in report Companies are constantly engaged in rigorous research and development activities to expand their presence in this market. For which, companies are come up with novel and technological advanced drug devices to capture large customer base. For instance, in November 2016, Abbott Laboratories received USFDA approval for ABSORB, bioresorbable stent for commercialization in Japan and in Canada (in July 2016). Such approvals will help companies to expand their presence in different geographies hence support the market growth.

Click here to obtain more highlight on “Drug Device Combination Market, By Product And Geography– Analysis, Share, Trends, Size, & Forecast From 2014 – 2025” study @
www.analystviewmarketinsights.com/industry-highlight-drug-device-combination-market-111/

Global Drug Device Combination Market: Snapshot

Market, by Product
- Orthopedic products
- Inhalers
- Photodynamic therapy devices
- Infusion pump
- Transdermal patches
- Drug eluting stents
- Antimicrobial catheters
- Others

Market, by Region
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
- Rest of the World

Market, by Country
- U.S.
- Canada
- Germany
- France
- India
- China

Key players profiled in this report with special attention on competitive landscape includes, (can be further customized to include additional 10 profiles of companies):
- Abbott Laboratories
- Stryker Corporation
- Medtronic
- Teleflex Incorporated
- Allergan, Inc.

USP of our key vendor analysis:
Well-designed strategic framework design for these key players will help to understand the market movement including regional expansion, mergers & acquisitions, and new product developments
Thorough SWOT i.e. Strength, Weakness, Opportunities and Threat for individual company profiling is analyzed in order to present a detailed market opportunity assessment.

Key benefits of the report:
• The report presents a macro and micro-level outlook regarding the industry. Thus, it becomes easy for our clients to perceive the business landscape and take a glimpse of their own standing in it.
• A thorough analysis of relevant statistical data to estimate the market paradigms
• Exceptional understanding of region and country-specific markets. The report will answer some of the toughest questions regarding the market shares, sizes, forecasts segmentations, and growth specific to the countries.
• Well-designed strategic framework analyzes the market movements including regional expansion, mergers & acquisitions, and new product developments

Research Methodology:
- Preliminary Data Mining: Secondary Research, Paid Databases, Primary Research
- Data Synthesis & Analysis: Top-Down Approach, Bottom-Up Approach, Supply Side and Demand Side
- Market Formulation: Market Dynamics, Total Addressable Market and Machine Learning Technique
- Data Verification: Quality Assurance and Reach a Conclusion
To enquire more about our research process and report store, please connect @
https://www.analystviewmarketinsights.com/get-in-touch/

About Us
AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends for various industries such as Healthcare, Bulk Chemicals, Semiconductors, Electronics, and Foods and Beverages.

Contact Us
Mr. Jose (Press & Marketing Manager)
Corporate Sales, USA
AnalystView Market Insights
Email: sales@analystviewmarketinsights.com
Tel: +91-757-498-5725 (Asia-Pacific Business Centre)
Web: www.analystviewmarketinsights.com

This release was published on openPR.